The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

The Journal also reported that the FDA is allowing Neuralink to move forward with a second patient, which comes days after the company had opened up applications. The implant is about the size of ...

Neuralink hopes to embed the chip system in a second patient in June, with the goal of implanting ten people by the end of the year. More than 1,000 quadriplegics have signed up for the company ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Musk has business interests that depend heavily on government regulation, subsidies or policy, from Tesla’s electric cars to ...

Elon Musk's brain chip firm Neuralink has said that the US Food and Drug Administration (FDA) has approved its first human clinical trial, a critical milestone after earlier struggles to gain ...

Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

Tom Oxley, the Australian-born chief executive of brain chip company Synchron, has praised ­Donald Trump for having a ...

Neuralink's second brain implant shows promise as the company aims to enhance the quality of life for individuals with spinal ...

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...